Deccan Remedies Ltd, a active public limited company, was established on 31 January 1994 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U72200TG1994PLC016962. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹12.42 Cr.
It upholds a compliant status. Its leadership includes Arihant Baid (Managing Director), Addala Venkata Ratna Harsha (Director), Venkata Lakshmi Narayana Bhaswanth Komaragiri (Additional Director). Past directors included Prabir Kumar Sarkar, Dinesh Kumar Kejriwal, Laxmipat Baid. It holds ₹24.28 Cr open charges and ₹17.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.144, Mch.No. 8-3-1053, Akash Ganga 4Th Floor, Srinagar Colony, Hyderabad, Telangana, 500073.
U72200TG1994PLC016962
016962
31 January 1994
₹15.00 Cr
₹12.42 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Deccan Remedies Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arihant Baid | Managing Director | 28 Nov 2022 | Current |
| Addala Venkata Ratna Harsha | Director | 01 Mar 2023 | Current |
| Venkata Lakshmi Narayana Bhaswanth Komaragiri | Additional Director | 09 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Apr 2015 | Past |
| Pramod Abcsdd | Company Secretary | 07 Apr 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 19 Apr 2023 | Past |
| Pramod Abcsdd | Director | 30 Jan 2024 | Past |
| Pramod Abcsdd | Director | 03 Dec 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Deccan Remedies Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 2.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Deccan Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹242,750,000.00
₹177,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2023 | Others | ₹16.78 Cr | Open |
| 16 Mar 2023 | Others | ₹7.50 Cr | Open |
| 01 Feb 1999 | Andhra Bank | ₹2.00 Cr | Satisfied |
| 26 Mar 1998 | Industrial Investment Bank Of India | ₹1.00 Cr | Satisfied |
| 20 Feb 1998 | Industrial Development Bank Of India | ₹3.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Deccan Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Deccan Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deccan Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Venkata Lakshmi Narayana Bhaswanth Komaragiri was appointed as a Additional Director was appointed as a Additional Director on 09 Oct 2025 & has been associated with this company since 2 months 19 days . was documented.
Progress on A charge with Others of Rs. 16.78 Cr registered on 16 Mar 2023 with Charge ID 100691676 was modified on 24 Sep 2025. was documented.
A charge with Others of Rs. 7.50 Cr registered on 16 Mar 2023 with Charge ID 100691620 was modified on 24 Sep 2025. was recorded as a recent event.
Deccan Remedies Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Deccan Remedies Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Progress on Dinesh Kumar Kejriwal was appointed as a Company Secretary was appointed as a Company Secretary on 26 May 2023 & has been associated with this company since 2 years 7 months . was documented.
The CIN of Deccan Remedies Ltd is U72200TG1994PLC016962.
Deccan Remedies Ltd is headquartered at Plot No.144, Mch.No. 8-3-1053, Akash Ganga 4Th Floor, Srinagar Colony, Hyderabad, Telangana, 500073.
Deccan Remedies Ltd was incorporated on 31 January 1994.
The current directors of Deccan Remedies Ltd are
The primary industry of Deccan Remedies Ltd is Manufacturing.
Deccan Remedies Ltd is unlisted.
The authorized capital of Deccan Remedies Ltd is ₹15.00 Cr, and the paid-up capital is ₹12.42 Cr.
The compliance status of Deccan Remedies Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX